Targeting membrane androgen receptors in tumors

Expert Opinion on Therapeutic Targets

Volumn 17, Issue 8, 2013, Pages 951-963

  Lang, Florian ^a   Alevizopoulos, Konstantinos ^b   Stournaras, Christos ^a,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Medexis Biotech SA   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

Actin cytoskeleton; Androgens; Apoptosis; Cell proliferation; MAR expression; MAR ligands; MAR signaling; Migration; SGK1

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CYPROTERONE ACETATE; FLUTAMIDE; G PROTEIN COUPLED RECEPTOR; PACLITAXEL; PHOSPHATIDYLINOSITOL 3 KINASE; PROCYANIDIN; PROCYANIDIN B2; PROTEIN KINASE B; TEMOZOLOMIDE; TESTOSTERONE; TESTOSTERONE ALBUMIN CONJUGATE; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BINDING SITE; BREAST TUMOR; CANCER INHIBITION; CELL DEATH; CELL FUNCTION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; COLON TUMOR; DRUG EFFECT; DRUG EFFICACY; GLIOBLASTOMA; GLIOMA; HUMAN; IN VIVO STUDY; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR BIOLOGY; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TUMOR VOLUME;

ANDROGENS; ANIMALS; CELL MEMBRANE; HUMANS; NEOPLASMS; RECEPTORS, ANDROGEN;

EID: 84880371610     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2013.806491     Document Type: Review

References (105)

1. Falkenstein E, Norman AW, Wehling M. Mannheim classification of nongenomically initiated (rapid) steroid action(s). J Clin Endocrinol Metab 2000;85:2072-5 (Pubitemid 32269322)
2. Kousteni S, Bellido T, Plotkin LI, et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 2001;104:719-30 (Pubitemid 32241022)
3. Simoncini T, Genazzani AR. Non-genomic actions of sex steroid hormones. Eur J Endocrinol 2003;148:281-92 (Pubitemid 36410713)
4. Norman AW, Mizwicki MT, Norman DP. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 2004;3:27-41 (Pubitemid 38088696)
5. Farnsworth WE. Activities of the androgen-responsive receptor of the prostatic plasma membrane. Invest Urol 1977;15:75-7 (Pubitemid 8163526)
6. Farnsworth WE. The prostate plasma membrane as an androgen receptor. Membr Biochem 1990;9:141-62
7. Farnsworth WE. Prostate plasma membrane receptor: a hypothesis. Prostate 1991;19:329-52
8. Farnsworth WE. Na+,K(+)-ATPase: the actual androgen receptor of the prostate? Med Hypotheses 1993;41:358-62
9. Ramirez VD, Zheng J, Siddique KM. Membrane receptors for estrogen, progesterone, and testosterone in the rat brain: fantasy or reality. Cell Mol Neurobiol 1996;16:175-98 (Pubitemid 26158376)
10. Benten WP, Lieberherr M, Giese G, et al. Functional testosterone receptors in plasma membranes of T cells. FASEB J 1999;13:123-33 (Pubitemid 29038282)
11. Benten WP, Lieberherr M, Stamm O, et al. Testosterone signaling through internalizable surface receptors in androgen receptor-free macrophages. Mol Biol Cell 1999;10:3113-23 (Pubitemid 29489549)
12. Guo Z, Benten WP, Krucken J, et al. Nongenomic testosterone calcium signaling. Genotropic actions in androgen receptor-free macrophages. J Biol Chem 2002;277:29600-7 (Pubitemid 41079249)
13. Wunderlich F, Benten WP, Lieberherr M, et al. Testosterone signaling in T cells and macrophages. Steroids 2002;67:535-8 (Pubitemid 34311771)
14. ElBaradie K, Wang Y, Boyan BD, et al. Rapid membrane responses to dihydrotestosterone are sex dependent in growth plate chondrocytes. J Steroid Biochem Mol Biol 2012;132:15-23
15. Gatson JW, Singh M. Activation of a membrane-associated androgen receptor promotes cell death in primary cortical astrocytes. Endocrinology 2007;148:2458-64 (Pubitemid 46997068)
16. Alexaki VI, Dermitzaki E, Charalampopoulos I, et al. Neuronal differentiation of PC12 cells abolishes the expression of membrane androgen receptors. Exp Cell Res 2006;312:2745-56
17. Somjen D, Kohen F, Gayer B, et al. Role of putative membrane receptors in the effect of androgens on human vascular cell growth. J Endocrinol 2004;180:97-106 (Pubitemid 38180761)
18. Vicencio JM, Ibarra C, Estrada M, et al. Testosterone induces an intracellular calcium increase by a nongenomic mechanism in cultured rat cardiac myocytes. Endocrinology 2006;147:1386-95 (Pubitemid 43244373)
19. Estrada M, Espinosa A, Muller M, et al. Testosterone stimulates intracellular calcium release and mitogen-activated protein kinases via a G protein-coupled receptor in skeletal muscle cells. Endocrinology 2003;144:3586-97 (Pubitemid 36904438)
20. Gorczynska E, Handelsman DJ. Androgens rapidly increase the cytosolic calcium concentration in Sertoli cells. Endocrinology 1995;136:2052-9
21. Castoria G, Lombardi M, Barone MV, et al. Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. J Cell Biol 2003;161:547-56 (Pubitemid 36578579)
22. Armen TA, Gay CV. Simultaneous detection and functional response of testosterone and estradiol receptors in osteoblast plasma membranes. J Cell Biochem 2000;79:620-7
23. Machelon V, Nome F, Tesarik J. Nongenomic effects of androstenedione on human granulosa luteinizing cells. J Clin Endocrinol Metab 1998;83:263-9 (Pubitemid 28498348)
24. Cinar B, Mukhopadhyay NK, Meng G, et al. Phosphoinositide 3-kinase-independent non-genomic signals transit from the androgen receptor to Akt1 in membrane raft microdomains. J Biol Chem 2007;282:29584-93 (Pubitemid 350043392)
25. Kampa M, Papakonstanti EA, Hatzoglou A, et al. The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors that increase PSA secretion and modify actin cytoskeleton. FASEB J 2002;16:1429-31
26. Migliaccio A, Castoria G, Di Domenico M, et al. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J 2000;19:5406-17
27. Papakonstanti EA, Kampa M, Castanas E, et al. A rapid, nongenomic, signaling pathway regulates the actin reorganization induced by activation of membrane testosterone receptors. Mol Endocrinol 2003;17:870-81 (Pubitemid 36539577)
28. Sun YH, Gao X, Tang YJ, et al. Androgens induce increases in intracellular calcium via a G protein-coupled receptor in LNCaP prostate cancer cells. J Androl 2006;27:671-8 (Pubitemid 44520808)
29. Hatzoglou A, Kampa M, Kogia C, et al. Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo. J Clin Endocrinol Metab 2005;90:893-903 (Pubitemid 40279214)
30. Papadopoulou N, Charalampopoulos I, Alevizopoulos K, et al. Rho/ROCK/actin signaling regulates membrane androgen receptor induced apoptosis in prostate cancer cells. Exp Cell Res 2008;314:3162-74
31. Sen A, O'Malley K, Wang Z, et al. Paxillin regulates androgen-and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells. J Biol Chem 2010;285:28787-95
32. Pelekanou V, Notas G, Sanidas E, et al. Testosterone membrane-initiated action in breast cancer cells: interaction with the androgen signaling pathway and EPOR. Mol Oncol 2010;4:135-49
33. Kallergi G, Agelaki S, Markomanolaki H, et al. Activation of FAK/PI3K/Rac1 signaling controls actin reorganization and inhibits cell motility in human cancer cells. Cell Physiol Biochem 2007;20:977-86 (Pubitemid 350059740)
34. Gatson JW, Kaur P, Singh M. Dihydrotestosterone differentially modulates the mitogen-activated protein kinase and the phosphoinositide 3-kinase/Akt pathways through the nuclear and novel membrane androgen receptor in C6 cells. Endocrinology 2006;147:2028-34
35. Singh M. Enhancing effectiveness of glial cancer therapies. US20120040914A1; 2012
36. Gu S, Papadopoulou N, Gehring EM, et al. Functional membrane androgen receptors in colon tumors trigger pro-apoptotic responses in vitro and reduce drastically tumor incidence in vivo. Mol Cancer 2009;8:114
37. Gu S, Papadopoulou N, Nasir O, et al. Activation of membrane androgen receptors in colon cancer inhibits the prosurvival signals Akt/bad in vitro and in vivo and blocks migration via vinculin/actin signaling. Mol Med 2011;17:48-58
38. Kampa M, Kogia C, Theodoropoulos PA, et al. Activation of membrane androgen receptors potentiates the antiproliferative effects of paclitaxel on human prostate cancer cells. Mol Cancer Ther 2006;5:1342-51 (Pubitemid 43881328)
39. Papadopoulou N, Charalampopoulos I, Anagnostopoulou V, et al. Membrane androgen receptor activation triggers down-regulation of PI3K/Akt/NFkappaB activity and induces apoptotic responses via Bad, FasL and caspase-3 in DU145 prostate cancer cells. Mol Cancer 2008;7:88
40. Kline LW, Karpinski E. Testosterone and dihydrotestosterone inhibit gallbladder motility through multiple signalling pathways. Steroids 2008;73:1174-80
41. Schmidt EM, Gu S, Anagnostopoulou V, et al. Serum-and glucocorticoid-dependent kinase-1-induced cell migration is dependent on vinculin and regulated by the membrane androgen receptor. FEBS J 2012;279:1231-42
42. Boonyaratanakornkit V, Edwards DP. Receptor mechanisms mediating non-genomic actions of sex steroids. Semin Reprod Med 2007;25:139-53 (Pubitemid 46676901)
43. Castoria G, Lombardi M, Barone MV, et al. Rapid signalling pathway activation by androgens in epithelial and stromal cells. Steroids 2004;69:517-22 (Pubitemid 39013481)
44. Foradori CD, Weiser MJ, Handa RJ. Non-genomic actions of androgens. Front Neuroendocrinol 2008;29:169-81
45. Hammes SR, Levin ER. Minireview: recent advances in extranuclear steroid receptor actions. Endocrinology 2011;152:4489-95
46. Kampa M, Pelekanou V, Castanas E. Membrane-initiated steroid action in breast and prostate cancer. Steroids 2008;73:953-60
47. Lange CA, Gioeli D, Hammes SR, et al. Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer. Annu Rev Physiol 2007;69:171-99 (Pubitemid 46457640)
48. Michels G, Hoppe UC. Rapid actions of androgens. Front Neuroendocrinol 2008;29:182-98
49. Papadopoulou N, Papakonstanti EA, Kallergi G, et al. Membrane androgen receptor activation in prostate and breast tumor cells: molecular signaling and clinical impact. IUBMB Life 2009;61:56-61
50. Rahman F, Christian HC. Non-classical actions of testosterone: an update. Trends Endocrinol Metab 2007;18:371-8 (Pubitemid 350137764)
51. Vasconsuelo A, Pronsato L, Ronda AC, et al. Role of 17beta-estradiol and testosterone in apoptosis. Steroids 2011;76:1223-31
52. Benten WP, Lieberherr M, Sekeris CE, et al. Testosterone induces Ca2+ influx via non-genomic surface receptors in activated T cells. FEBS Lett 1997;407:211-14 (Pubitemid 27199494)
53. Gonzalez-Montelongo MC, Marin R, Gomez T, et al. Androgens are powerful non-genomic inducers of calcium sensitization in visceral smooth muscle. Steroids 2010;75:533-8
54. Nifli AP, Bosson-Kouame A, Papadopoulou N, et al. Monomeric and oligomeric flavanols are agonists of membrane androgen receptors. Exp Cell Res 2005;309:329-39 (Pubitemid 41317356)
55. Gu S, Kounenidakis M, Schmidt EM, et al. Rapid activation of FAK/mTOR/p70S6K/PAK1-signaling controls the early testosterone-induced actin reorganization in colon cancer cells. Cell Signal 2013;25:66-73
56. Alimirah F, Chen J, Basrawala Z, et al. DU145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation. FEBS Lett 2006;580:2294-300 (Pubitemid 43675636)
57. Mitchell S, Abel P, Ware M, et al. Phenotypic and genotypic characterization of commonly used human prostatic cell lines. BJU Int 2000;85:932-44 (Pubitemid 30242804)
58. Lang F, Perrotti N, Stournaras C. Colorectal carcinoma cells-regulation of survival and growth by SGK1. Int J Biochem Cell Biol 2010;42:1571-5
59. Lang F, Voelkl J. Therapeutic potential of serum and glucocorticoid inducible kinase inhibition. Expert Opin Investig Drugs 2013
60. Schmidt EM, Kraemer BF, Borst O, et al. SGK1 sensitivity of platelet migration. Cell Physiol Biochem 2012;30:259-68
61. Schmid E, Bhandaru M, Nurbaeva MK, et al. SGK3 regulates Ca(2+) entry and migration of dendritic cells. Cell Physiol Biochem 2012;30:1423-35
62. Bhandaru M, Pasham V, Yang W, et al. Effect of azathioprine on Na(+)/H(+) exchanger activity in dendritic cells. Cell Physiol Biochem 2012;29:533-42
63. Rotte A, Pasham V, Eichenmuller M, et al. Influence of dexamethasone on Na+/H+ exchanger activity in dendritic cells. Cell Physiol Biochem 2011;28:305-14
64. Pedersen SF, Hoffmann EK. Possible interrelationship between changes in F-actin and myosin II, protein phosphorylation, and cell volume regulation in Ehrlich ascites tumor cells. Exp Cell Res 2002;277:57-73 (Pubitemid 34948340)
65. Jakab M, Ritter M. Cell volume regulatory ion transport in the regulation of cell migration. Contrib Nephrol 2006;152:161-80 (Pubitemid 44672107)
66. Stock C, Schwab A. Role of the Na/H exchanger NHE1 in cell migration. Acta Physiol (Oxf) 2006;187:149-57 (Pubitemid 43828772)
67. Loo SY, Chang MK, Chua CS, et al. NHE-1: a promising target for novel anti-cancer therapeutics. Curr Pharm Des 2012;18:1372-82
68. Chien EJ, Chang CP, Lee WF, et al. Non-genomic immunosuppressive actions of progesterone inhibits PHA-induced alkalinization and activation in T cells. J Cell Biochem 2006;99:292-304 (Pubitemid 44297972)
69. Schmid E, Gu S, Yang W, et al. Serumand glucocorticoid-inducible kinase SGK1 regulates reorganization of actin cytoskeleton in mast cells upon degranulation. Am J Physiol Cell Physiol 2013;304:C49-55
70. Pedram A, Razandi M, Sainson RC, et al. A conserved mechanism for steroid receptor translocation to the plasma membrane. J Biol Chem 2007;282:22278-88 (Pubitemid 47267344)
71. Freeman MR, Cinar B, Lu ML. Membrane rafts as potential sites of nongenomic hormonal signaling in prostate cancer. Trends Endocrinol Metab 2005;16:273-9 (Pubitemid 41058759)
72. Razandi M, Pedram A, Levin ER. Heat shock protein 27 is required for sex steroid receptor trafficking to and functioning at the plasma membrane. Mol Cell Biol 2010;30:3249-61
73. Yu J, Akishita M, Eto M, et al. Src kinase-mediates androgen receptor-dependent non-genomic activation of signaling cascade leading to endothelial nitric oxide synthase. Biochem Biophys Res Commun 2012;424:538-43
74. Lieberherr M, Grosse B. Androgens increase intracellular calcium concentration and inositol 1,4,5-trisphosphate and diacylglycerol formation via a pertussis toxin-sensitive G-protein. J Biol Chem 1994;269:7217-23
75. Kampa M, Nifli AP, Charalampopoulos I, et al. Opposing effects of estradiol-and testosterone-membrane binding sites on T47D breast cancer cell apoptosis. Exp Cell Res 2005;307:41-51 (Pubitemid 40732732)
76. Filardo EJ, Quinn JA, Frackelton AR Jr, et al. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 2002;16:70-84 (Pubitemid 34044499)
77. Zhu Y, Bond J, Thomas P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci USA 2003;100:2237-42 (Pubitemid 36297483)
78. Gonzalez-Velazquez W, Gonzalez-Mendez R, Rodriguez-del Valle N. Characterization and ligand identification of a membrane progesterone receptor in fungi: existence of a novel PAQR in Sporothrix schenckii. BMC Microbiol 2012;12:194
79. Thomas P, Dressing G, Pang Y, et al. Progestin, estrogen and androgen G-protein coupled receptors in fish gonads. Steroids 2006;71:310-16
80. Pi M, Parrill AL, Quarles LD. GPRC6A mediates the non-genomic effects of steroids. J Biol Chem 2010;285:39953-64
81. Bonaccorsi L, Muratori M, Carloni V, et al. The androgen receptor associates with the epidermal growth factor receptor in androgen-sensitive prostate cancer cells. Steroids 2004;69:549-52 (Pubitemid 39013486)
82. Kampa M, Papakonstanti EA, Alexaki VI, et al. The opioid agonist ethylketocyclazocine reverts the rapid, non-genomic effects of membrane testosterone receptors in the human prostate LNCaP cell line. Exp Cell Res 2004;294:434-45 (Pubitemid 38326742)
83. Farnsworth WE. The androgen receptor of the prostate plasma membrane-an hypothesis. Med Hypotheses 2004;62:954-7 (Pubitemid 38680367)
84. Kallergi G, Tsapara A, Kampa M, et al. Distinct signaling pathways regulate differential opioid effects on actin cytoskeleton in malignant MCF7 and nonmalignant MCF12A human breast epithelial cells. Exp Cell Res 2003;288:94-109 (Pubitemid 36873805)
85. Koukouritaki SB, Theodoropoulos PA, Margioris AN, et al. Dexamethasone alters rapidly actin polymerization dynamics in human endometrial cells: evidence for nongenomic actions involving cAMP turnover. J Cell Biochem 1996;62:251-61 (Pubitemid 26287209)
86. Koukouritaki SB, Margioris AN, Gravanis A, et al. Dexamethasone induces rapid actin assembly in human endometrial cells without affecting its synthesis. J Cell Biochem 1997;65:492-500 (Pubitemid 27240915)
87. Koukouritaki SB, Gravanis A, Stournaras C. Tyrosine phosphorylation of focal adhesion kinase and paxillin regulates the signaling mechanism of the rapid nongenomic action of dexamethasone on actin cytoskeleton. Mol Med 1999;5:731-42 (Pubitemid 32937033)
88. Charalampopoulos I, Dermitzaki E, Vardouli L, et al. Dehydroepiandrosterone sulfate and allopregnanolone directly stimulate catecholamine production via induction of tyrosine hydroxylase and secretion by affecting actin polymerization. Endocrinology 2005;146:3309-18 (Pubitemid 41058102)
89. Carpenter CL. Actin cytoskeleton and cell signaling. Crit Care Med 2000;28:N94-9 (Pubitemid 30262052)
90. Stournaras C, Stiakaki E, Koukouritaki SB, et al. Altered actin polymerization dynamics in various malignant cell types: evidence for differential sensitivity to cytochalasin B. Biochem Pharmacol 1996;52:1339-46 (Pubitemid 26366357)
91. Ting HJ, Chang C. Actin associated proteins function as androgen receptor coregulators: an implication of androgen receptor's roles in skeletal muscle. J Steroid Biochem Mol Biol 2008;111:157-63
92. Kampa M, Theodoropoulou K, Mavromati F, et al. Novel oligomeric proanthocyanidin derivatives interact with membrane androgen sites and induce regression of hormone-independent prostate cancer. J Pharmacol Exp Ther 2011;337:24-32
93. Franklin-Tong VE, Gourlay CW. A role for actin in regulating apoptosis/programmed cell death: evidence spanning yeast, plants and animals. Biochem J 2008;413:389-404
94. Gourlay CW, Ayscough KR. The actin cytoskeleton: a key regulator of apoptosis and ageing? Nat Rev Mol Cell Biol 2005;6:583-9 (Pubitemid 40943049)
95. Papakonstanti EA, Stournaras C. Tumor necrosis factor-alpha promotes survival of opossum kidney cells via Cdc42-induced phospholipase C-gamma1 activation and actin filament redistribution. Mol Biol Cell 2004;15:1273-86 (Pubitemid 38316234)
96. Papakonstanti EA, Stournaras C. Cell responses regulated by early reorganization of actin cytoskeleton. FEBS Lett 2008;582:2120-7
97. Stournaras C. The functional role of actin cytoskeleton dynamics and signaling in early cell responses. In: Khurana S, editor, Advances in molecular and cell biology. Elsevier, London, UK; 2006. p. 181-200 (Pubitemid 44827948)
98. Moustakas A, Theodoropoulos PA, Gravanis A, et al. The cytoskeleton in cell volume regulation. Contrib Nephrol 1998;123:121-34
99. Papakonstanti EA, Vardaki EA, Stournaras C. Actin cytoskeleton: a signaling sensor in cell volume regulation. Cell Physiol Biochem 2000;10:257-64 (Pubitemid 32010734)
100. Smith KJ, Johnson KA, Bryan TM, et al. The APC gene product in normal and tumor cells. Proc Natl Acad Sci USA 1993;90:2846-50 (Pubitemid 23113514)
101. Dambaki C, Kogia C, Kampa M, et al. Membrane testosterone binding sites in prostate carcinoma as a potential new marker and therapeutic target: study in paraffin tissue sections. BMC Cancer 2005;5:148
102. Stathopoulos EN, Dambaki C, Kampa M, et al. Membrane androgen binding sites are preferentially expressed in human prostate carcinoma cells. BMC Clin Pathol 2003;3:1
103. Harrington WR, Kim SH, Funk CC, et al. Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action. Mol Endocrinol 2006;20:491-502 (Pubitemid 43291204)
104. Alevizopoulos K, Bacopoulos N, Stournaras C. Membrane androgen receptor ligands; a novel therapeutic approach for the treatment of cancer. Cancer Res 2010;70:1728
105. Bacopoulos N, Alevizopoulos K, Buchanan RL, et al. Detection of Membrane Androgen Receptor (MAR) agents. US20090104122;2009